Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection.
Schleiss
Mark R
MR
Division of Pediatric Infectious Diseases, Department of Pediatrics, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA. schleiss@umn.edu
D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000151:congenital / Q000517:prevention & control*; D022482:Cytomegalovirus Vaccines; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D011247:Pregnancy; D019444:Vaccines, DNA; D014771:Virion / Q000648:ultrastructure
D022482:Cytomegalovirus Vaccines; D019444:Vaccines, DNA